跳至主要内容
临床试验/ISRCTN49960746
ISRCTN49960746已完成未知

The efficacy and safety of 2g strontium ranelate in the treatment of male osteoporosis.A prospective multicentre, international, double-blind, placebo-controlled study with a treatment duration of 2 years and the main study analysis after 1 year. - MALEO

Institut de Recherches Internationales Servier (France)0 个研究点目标入组 221 人开始时间: 2007年11月30日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
221

研究概览

研究设计

研究类型
Interventional

入排标准

性别
Male

入选标准

  • •1. Caucasian males of at least 65 years of age
  • •2. Osteoporosis

排除标准

  • •1. BMD T-score less than -4.0
  • •2. More than two prevalent mild and/or moderate osteoporotic vertebral fractures
  • •3. Severe osteoporotic vertebral fractures

研究者

发起方
Institut de Recherches Internationales Servier (France)

相似试验

进行中(未招募)
1 期
The efficacy and safety of 2g strontium ranelate in the treatment of male osteoporosis.A prospective multicentre, international, double-blind, placebo-controlled study with a treatment duration of 2 years and the main study analysis after 1 year. - MALEOmale osteoporosisMedDRA version: 9.1Level: PTClassification code 10031282Term: Osteoporosis
EUCTR2006-006086-16-FRInstitut de Recherches Internationales Servier221
进行中(未招募)
不适用
The efficacy and safety of 2g strontium ranelate in the treatment of male osteoporosis.A prospective multicentre, international, double-blind, placebo-controlled study with a treatment duration of 2 years and the main study analysis after 1 year. - MALEOmale osteoporosisMedDRA version: 9.1Level: PTClassification code 10031282Term: Osteoporosis
EUCTR2006-006086-16-SEInstitut de Recherches Internationales Servier221
进行中(未招募)
1 期
The efficacy and safety of 2g strontium ranelate in the treatment of osteoporosis in men. A prospective multicentre, international, double-blind, placebo-controlled study with a treatment duration of 2 years and the main study analysis after 1 year.Osteoporosis in menMedDRA version: 9.1Level: PTClassification code 10031282Term: Osteoporosis
EUCTR2006-004717-17-CZInstitut de Recherches Internationales Servier221
进行中(未招募)
不适用
The efficacy and safety of 2g strontium ranelate in the treatment of osteoporosis in men. A prospective multicentre, international, double-blind, placebo-controlled study with a treatment duration of 2 years and the main study analysis after 1 year.Osteoporosis in menMedDRA version: 9.1Level: PTClassification code 10031282Term: Osteoporosis
EUCTR2006-004717-17-EEInstitut de Recherches Internationales Servier221
进行中(未招募)
不适用
The efficacy and safety of 2g strontium ranelate in the treatment of male osteoporosis.A prospective multicentre, international, double-blind, placebo-controlled study with a treatment duration of 2 years and the main study analysis after 1 year.Eficacia y seguridad de 2 g de ranelato de estroncio en el tratamiento de la osteoporosis en hombre. Estudio prospectivo, multicéntrico, internacional, doble ciego, controlado frente a placebo con una duración del tratamiento de 2 años y el análisis principal del estudio tras 1 año. - MALEOmale osteoporosisMedDRA version: 9.1Level: PTClassification code 10031282Term: Osteoporosis
EUCTR2006-006086-16-ESaboratorios Servier S.L.221